159 related articles for article (PubMed ID: 19348179)
41. Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association.
Toscano A; Rodolico C; Benvenga S; Girlanda P; Laurà M; Mazzeo A; Nobile-Orazio E; Trimarchi F; Vita G; Messina C
Neuromuscul Disord; 2002 Aug; 12(6):566-8. PubMed ID: 12117481
[TBL] [Abstract][Full Text] [Related]
42. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
43. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
[TBL] [Abstract][Full Text] [Related]
44. Acute inflammatory neuropathy with monoclonal anti-GM2 IgM antibodies, IgM-κ paraprotein and additional autoimmune processes in association with a diffuse large B-cell non-Hodgkin's lymphoma.
Milnik A; Roggenbuck D; Conrad K; Bartels C
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23341581
[TBL] [Abstract][Full Text] [Related]
45. Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats.
Halstead SK; Jackson M; Bianchi E; Rupp S; Granger N; Menchetti M; Galli G; Freeman P; Kaczmarska A; Bhatti SFM; Brocal J; José-López R; Tipold A; Gutierrez Quintana R; Ives EJ; Liatis T; Nessler J; Rusbridge C; Willison HJ; Rupp A
J Peripher Nerv Syst; 2023 Mar; 28(1):32-40. PubMed ID: 36573790
[TBL] [Abstract][Full Text] [Related]
46. [A case of chronic pure motor neuropathy associated with anti-GalNAc-GD1a-IgM antibody].
Kanzaki A; Endo S; Kusunoki S; Yoshinaga J; Nakamura Y; Shirabe T
No To Shinkei; 2003 Jul; 55(7):609-12. PubMed ID: 12910996
[TBL] [Abstract][Full Text] [Related]
47. Intravenous immunoglobulin treatment in multifocal motor neuropathy.
van der Pol WL; Cats EA; van den Berg LH
J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S79-83. PubMed ID: 20405181
[TBL] [Abstract][Full Text] [Related]
48. IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.
Bansal AS; Abdul-Karim B; Malik RA; Goulding P; Pumphrey RS; Boulton AJ; Holt PL; Wilson PB
J Clin Pathol; 1994 Apr; 47(4):300-2. PubMed ID: 8027366
[TBL] [Abstract][Full Text] [Related]
49. Cloning of human anti-GM1 antibodies from motor neuropathy patients.
Willison HJ; Paterson G; Kennedy PG; Veitch J
Ann Neurol; 1994 Apr; 35(4):471-8. PubMed ID: 8154875
[TBL] [Abstract][Full Text] [Related]
50. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Lopate G; Choksi R; Pestronk A
Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
[TBL] [Abstract][Full Text] [Related]
51. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide.
Pestronk A; Lopate G; Kornberg AJ; Elliott JL; Blume G; Yee WC; Goodnough LT
Neurology; 1994 Nov; 44(11):2027-31. PubMed ID: 7969954
[TBL] [Abstract][Full Text] [Related]
52. Anti-GM1/GD1b M-proteins damage human spinal cord neurons co-cultured with muscle.
Heiman-Patterson T; Krupa T; Thompson P; Nobile-Orazio E; Tahmoush AJ; Shy ME
J Neurol Sci; 1993 Dec; 120(1):38-45. PubMed ID: 8289078
[TBL] [Abstract][Full Text] [Related]
53. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.
Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E
J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036
[TBL] [Abstract][Full Text] [Related]
54. Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b.
Noguchi M; Mori K; Yamazaki S; Suda K; Sato N; Oshimi K
Br J Haematol; 2003 Nov; 123(4):600-5. PubMed ID: 14616962
[TBL] [Abstract][Full Text] [Related]
55. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups.
Ilyas AA; Quarles RH; Dalakas MC; Fishman PH; Brady RO
Ann Neurol; 1985 Dec; 18(6):655-9. PubMed ID: 2417543
[TBL] [Abstract][Full Text] [Related]
57. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro.
Heidenreich F; Leifeld L; Jovin T
J Neuroimmunol; 1994 Jan; 49(1-2):97-108. PubMed ID: 8294565
[TBL] [Abstract][Full Text] [Related]
58. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.
Nobile-Orazio E; Meucci N; Barbieri S; Carpo M; Scarlato G
Neurology; 1993 Mar; 43(3 Pt 1):537-44. PubMed ID: 8450997
[TBL] [Abstract][Full Text] [Related]
59. Lower motor neuron syndrome associated with anti-GM1 antibodies.
Villa A; Molina H; Sanz OP; Garreto N; Kholer G; Sica RE
Medicina (B Aires); 1997; 57(3):270-4. PubMed ID: 9640758
[TBL] [Abstract][Full Text] [Related]
60. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K
J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
